SST3 receptor (ssr3_human)
FAMILY
Class A (Rhodopsin) Peptide receptors Somatostatin receptors SST3 receptor
GENE
SSTR3
ORGANISM
Human (Homo sapiens)
ALT. NAMES
Somatostatin receptor type 3, SS-3-R, SS3-R, SS3R, SST3, SSR-28
SOURCE
SWISSPROT
SEQUENCE
N-term | |||||||||
M
|
D
|
M
|
L
|
H
|
P
|
S
|
S
|
V
|
S
|
10 |
T
|
T
|
S
|
E
|
P
|
E
|
N
|
A
|
S
|
S
|
20 |
A
|
W
|
P
|
P
|
D
|
A
|
T
|
L
|
G
|
N
|
30 |
V
|
S
|
A
|
G
|
P
|
S
|
P
|
A
|
G
|
L
|
40 |
TM1 | |||||||||
A
|
V
|
S
|
G
|
V
|
L
|
I
|
P
|
L
|
V
|
50 |
Y
|
L
|
V
|
V
|
C
|
V
|
V
|
G
|
L
|
L
|
60 |
G
|
N
|
S
|
L
|
V
|
I
|
Y
|
V
|
V
|
L
|
70 |
ICL1 | TM2 | ||||||||
R
|
H
|
T
|
A
|
S
|
P
|
S
|
V
|
T
|
N
|
80 |
V
|
Y
|
I
|
L
|
N
|
L
|
A
|
L
|
A
|
D
|
90 |
E
|
L
|
F
|
M
|
L
|
G
|
L
|
P
|
F
|
L
|
100 |
ECL1 | |||||||||
A
|
A
|
Q
|
N
|
A
|
L
|
S
|
Y
|
W
|
P
|
110 |
TM3 | |||||||||
F
|
G
|
S
|
L
|
M
|
C
|
R
|
L
|
V
|
M
|
120 |
A
|
V
|
D
|
G
|
I
|
N
|
Q
|
F
|
T
|
S
|
130 |
I
|
F
|
C
|
L
|
T
|
V
|
M
|
S
|
V
|
D
|
140 |
R
|
Y
|
L
|
A
|
V
|
V
|
H
|
P
|
T
|
R
|
150 |
ICL2 | TM4 | ||||||||
S
|
A
|
R
|
W
|
R
|
T
|
A
|
P
|
V
|
A
|
160 |
R
|
T
|
V
|
S
|
A
|
A
|
V
|
W
|
V
|
A
|
170 |
S
|
A
|
V
|
V
|
V
|
L
|
P
|
V
|
V
|
V
|
180 |
ECL2 | |||||||||
F
|
S
|
G
|
V
|
P
|
R
|
G
|
M
|
S
|
T
|
190 |
C
|
H
|
M
|
Q
|
W
|
P
|
E
|
P
|
A
|
A
|
200 |
TM5 | |||||||||
A
|
W
|
R
|
A
|
G
|
F
|
I
|
I
|
Y
|
T
|
210 |
A
|
A
|
L
|
G
|
F
|
F
|
G
|
P
|
L
|
L
|
220 |
V
|
I
|
C
|
L
|
C
|
Y
|
L
|
L
|
I
|
V
|
230 |
V
|
K
|
V
|
R
|
S
|
A
|
G
|
R
|
R
|
V
|
240 |
ICL3 | TM6 | ||||||||
W
|
A
|
P
|
S
|
C
|
Q
|
R
|
R
|
R
|
R
|
250 |
S
|
E
|
R
|
R
|
V
|
T
|
R
|
M
|
V
|
V
|
260 |
A
|
V
|
V
|
A
|
L
|
F
|
V
|
L
|
C
|
W
|
270 |
M
|
P
|
F
|
Y
|
V
|
L
|
N
|
I
|
V
|
N
|
280 |
ECL3 | TM7 | ||||||||
V
|
V
|
C
|
P
|
L
|
P
|
E
|
E
|
P
|
A
|
290 |
F
|
F
|
G
|
L
|
Y
|
F
|
L
|
V
|
V
|
A
|
300 |
L
|
P
|
Y
|
A
|
N
|
S
|
C
|
A
|
N
|
P
|
310 |
H8 | |||||||||
I
|
L
|
Y
|
G
|
F
|
L
|
S
|
Y
|
R
|
F
|
320 |
K
|
Q
|
G
|
F
|
R
|
R
|
V
|
L
|
L
|
R
|
330 |
C-term | |||||||||
P
|
S
|
R
|
R
|
V
|
R
|
S
|
Q
|
E
|
P
|
340 |
T
|
V
|
G
|
P
|
P
|
E
|
K
|
T
|
E
|
E
|
350 |
E
|
D
|
E
|
E
|
E
|
E
|
D
|
G
|
E
|
E
|
360 |
S
|
R
|
E
|
G
|
G
|
K
|
G
|
K
|
E
|
M
|
370 |
N
|
G
|
R
|
V
|
S
|
Q
|
I
|
T
|
Q
|
P
|
380 |
G
|
T
|
S
|
G
|
Q
|
E
|
R
|
P
|
P
|
S
|
390 |
R
|
V
|
A
|
S
|
K
|
E
|
Q
|
Q
|
L
|
L
|
400 |
P
|
Q
|
E
|
A
|
S
|
T
|
G
|
E
|
K
|
S
|
410 |
S
|
T
|
M
|
R
|
I
|
S
|
Y
|
L
|
DIAGRAMS
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
CST-17, cortistatin-14, SRIF-28, SRIF-14
STRUCTURE MODELS
STRUCTURES
No structures available